Annual Retained Earnings
-$434.93 M
-$100.70 M-30.13%
December 31, 2023
Summary
- As of February 8, 2025, ORIC annual retained earnings is -$434.93 million, with the most recent change of -$100.70 million (-30.13%) on December 31, 2023.
- During the last 3 years, ORIC annual retained earnings has fallen by -$268.53 million (-161.39%).
- ORIC annual retained earnings is now -560.91% below its all-time high of -$65.81 million, reached on December 31, 2018.
Performance
ORIC Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$526.47 M
-$34.57 M-7.03%
September 30, 2024
Summary
- As of February 8, 2025, ORIC quarterly retained earnings is -$526.47 million, with the most recent change of -$34.57 million (-7.03%) on September 30, 2024.
- Over the past year, ORIC quarterly retained earnings has dropped by -$119.87 million (-29.48%).
- ORIC quarterly retained earnings is now -467.99% below its all-time high of -$92.69 million, reached on December 31, 2019.
Performance
ORIC Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
ORIC Retained Earnings Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -30.1% | -29.5% |
3 y3 years | -161.4% | -29.5% |
5 y5 years | -560.9% | -29.5% |
ORIC Retained Earnings Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -77.4% | at low | -114.8% | at low |
5 y | 5-year | -369.2% | at low | -468.0% | at low |
alltime | all time | -560.9% | at low | -468.0% | at low |
ORIC Pharmaceuticals Retained Earnings History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | -$526.47 M(+7.0%) |
Jun 2024 | - | -$491.90 M(+6.9%) |
Mar 2024 | - | -$459.94 M(+5.8%) |
Dec 2023 | -$434.93 M(+30.1%) | -$434.93 M(+7.0%) |
Sep 2023 | - | -$406.60 M(+6.7%) |
Jun 2023 | - | -$381.12 M(+6.4%) |
Mar 2023 | - | -$358.18 M(+7.2%) |
Dec 2022 | -$334.23 M | -$334.23 M(+6.7%) |
Sep 2022 | - | -$313.38 M(+8.6%) |
Jun 2022 | - | -$288.55 M(+7.6%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | -$268.27 M(+9.4%) |
Dec 2021 | -$245.11 M(+47.3%) | -$245.11 M(+10.2%) |
Sep 2021 | - | -$222.34 M(+9.0%) |
Jun 2021 | - | -$203.91 M(+11.5%) |
Mar 2021 | - | -$182.90 M(+9.9%) |
Dec 2020 | -$166.39 M(+79.5%) | -$166.39 M(+20.5%) |
Sep 2020 | - | -$138.13 M(+22.7%) |
Jun 2020 | - | -$112.59 M(+10.9%) |
Mar 2020 | - | -$101.56 M(+9.6%) |
Dec 2019 | -$92.69 M(+40.9%) | -$92.69 M |
Dec 2018 | -$65.81 M | - |
FAQ
- What is ORIC Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for ORIC Pharmaceuticals?
- What is ORIC Pharmaceuticals annual retained earnings year-on-year change?
- What is ORIC Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for ORIC Pharmaceuticals?
- What is ORIC Pharmaceuticals quarterly retained earnings year-on-year change?
What is ORIC Pharmaceuticals annual retained earnings?
The current annual retained earnings of ORIC is -$434.93 M
What is the all time high annual retained earnings for ORIC Pharmaceuticals?
ORIC Pharmaceuticals all-time high annual retained earnings is -$65.81 M
What is ORIC Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, ORIC annual retained earnings has changed by -$100.70 M (-30.13%)
What is ORIC Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of ORIC is -$526.47 M
What is the all time high quarterly retained earnings for ORIC Pharmaceuticals?
ORIC Pharmaceuticals all-time high quarterly retained earnings is -$92.69 M
What is ORIC Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, ORIC quarterly retained earnings has changed by -$119.87 M (-29.48%)